The impact of clinical practice guidelines and clinical trials on treatment decisions

Surgical Oncology

Volumn 11, Issue 4, 2002, Pages 255-262

  Darling, Gail ^a,b  

^a UNIVERSITY OF TORONTO   (Canada)

^b TORONTO GENERAL HOSPITAL   (Canada)

Author keywords

Clinical practice guidelines; Clinical trials; Evidence based medicine; Lung cancer

Indexed keywords

ANTINEOPLASTIC AGENT;

ADJUVANT CHEMOTHERAPY; CANCER RADIOTHERAPY; CANCER RISK; CANCER STAGING; CANCER SURGERY; CANCER SURVIVAL; CANCER THERAPY; CLINICAL PRACTICE; CLINICAL TRIAL; DECISION MAKING; EVALUATION; HEALTH; HUMAN; LUNG CANCER; LUNG NON SMALL CELL CANCER; MEDICAL LIABILITY; METHODOLOGY; POSTOPERATIVE CARE; PRACTICE GUIDELINE; PRIORITY JOURNAL; REVIEW; TREATMENT OUTCOME;

ANTINEOPLASTIC PROTOCOLS; CLINICAL TRIALS; DECISION MAKING; HUMANS; LUNG NEOPLASMS; NEOPLASM STAGING; OUTCOME ASSESSMENT (HEALTH CARE); PRACTICE GUIDELINES;

EID: 0036889832     PISSN: 09607404     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0960-7404(02)00046-4     Document Type: Review

References (52)

1. Williams C.J. Evidence based cancer care. Clinical Oncology. 10:1998;144-149.
2. Field MJ, Lohr KN, editors. Clinical Practice Guidelines: Directions for a New Program. Washington, DC: National Academy Press, 1990.
3. Gundersen L. The effect of clinical practice guidelines on variations in care. Annals Internal Medicine. 133(4):2000;317.
4. Evans W.K., Newman T., Graham I.et al. Lung cancer practice guidelines. lessons learned and issues addressed by the Ontario Lung Cancer Disease Site Group Journal of Clinical Oncology. 15(9):1997;3049-3059.
5. Graham D., Evans W.K., Logan D.et al. Canadian oncologists and clinical practice guidelines. a national survey of attitudes and reported use Oncology. 59:2000;283-290.
6. Menard J. Oil and water? Economic advantage and biomedical progress do not mix well in a government guidelines committee. American Journal of Hypertension. 7(10 part 1):1994;877-885.
7. Savoie I., Kazanjian A., Bassett K. Do clinical practice guidelines reflect research evidence? Journal of Health Services and Research Policy. 5(2):2000;76-82.
8. Rogers E.M. Lessons for guidelines from the diffusion of innovations. Joint Commission Journal on Quality Improvement. 21:1995;324-328.
9. Royal College of Radiologists Clinical Oncology Information Network. Guidelines on the nonsurgical management of lung cancer. Clinical Oncology 1999;11:S1-53.
10. Simmonds P. Managing patient with lung cancer. British Medical Journal. 319:1999;527-528.
11. Anonymous. Clinical practice guidelines for the treatment of unresectable non-small-cell lung cancer. Adopted on May 16, 1997 by the American Society of Clinical Oncology. Journal of Clinical Oncology 1997;15(8):2996-3018.
12. Okawara G., Rusthoven J., Newman T.et al. Unresected stage III non-small-cell lung cancer. Provincial Lung Cancer Disease Site Group. Canadian Preventive Control. 1(3):1997;249-259.
13. Lopez P.G., Stewart D.J., Newman T.E.et al. Chemotherapy in stage IV (metastatic) non-small-cell lung cancer. Provincial Lung Disease Site Group. Canadian Preventive Control. 1(1):1997;18-27.
14. Macbeth F. All evidence was considered when COIN guidelines were drawn up. British Medical Journal. 320:2000;1604.
15. O'Brien M., Cullen M. Guidelines must help bring us in line with European standards. British Medical Journal. 320:2000;1604.
16. Ardizzoni A., Grossi F., Salvati F.et al. Common international guidelines must be developed. British Medical Journal. 320:2000;379.
17. National Comprehensive Cancer Network Practice Guidelines in Oncology: Non-Small Cell Lung Cancer. 2002;1.
18. Grimshaw J.M., Russell I.T. Effect of clinical guidelines on medical practice. a systematic review of rigorous evaluations Lancet. 342(8883):1993;1317-1322.
19. Anonymous. Implementing clinical practice guidelines: Can guidelines be used to improve clinical practice? Database of Abstracts of Reviews of Effectiveness Vol. 1 2002;1.
20. McDonagh R.J., Lavis J.N., Sharpe G. Clinical Practice Guidelines as expert standards of care. medico-legal considerations Annals of the Royal College of Physicians and Surgeons of Canada. 35(1):2002;9-12.
21. Long M.J. Clinical practice guidelines. when the tool becomes the rule Journal of Evaluation in Clinical Practice. 7(2):2001;191-199.
22. Ellrodt A.G., Conner L., Riedinger M.et al. Measuring and improving physician compliance with clinical practice guidelines. A controlled interventional trial. Annals of Internal Medicine. 122(4):1995;277-282.
23. Lesscoe-Long M., Long M.J. Defining the utility of clinically acceptable variations in evidence-based practice guidelines for evaluation of quality improvement activities. Evaluation and the Health Professions. 22:1999;298-324.
24. Larkin M. Noncompliance with "best practices" may be justifiable. Lancet. 358(9291):2001;1433.
25. Donebedian A. The definition of Quality and Approaches to its Assessment Chicago, vol. 1. Chicago, IL: Health Administration Press, 1980.
26. Djulbegovic B., Hadley T. Evaluating the quality of clinical guidelines. Linking decisions to medical evidence. Oncology. 12(11A):1998;310-314.
27. Greenlee RT, Hill-Harmon B, Murry T, Thun M. Cancer Statistics 2001;CA 51(1):15-36.
28. Non-Small Cell Lung Cancer Collaborative Group. Chemotherapy in non-small cell lung cancer: A meta-analysis using updated individual patient data from 52 randomized clinical trials. British Medical Journal 1995;11(7):899-909.
29. Grilli R., Oxman A.D., Julian J.A. Chemotherapy for advanced non-small cell lung cancer. how much benefit is enough? Journal of Clinical Oncology. 11:1993;1866-1872.
30. Souquet P.J., Chauvin F., Boisel J.P.et al. Polychemotherapy in advanced non-small cell lung cancer. a meta-analysis Lancet. 342:1993;19-21.
31. Meta-analysis Trialists Group: Post-operative radiotherapy in non-small cell lung cancer. Systematic review and meta-analysis of individual patients data from randomized controlled trials. Lancet 1998;352:257-63.
32. Lung Cancer Study Group. Effect of postoperative mediastinal radiation on completely resected stage II and stage III epidermoid cancer of the lung. New England Journal of Medicine 1986;315:1377-81.
33. Medical Research Council Working Party. The role of post-operative radiotherapy in non-small cell lung cancer: A multicentre randomized trial in patients with pathologically staged T1-2, N1-2, M0 disease. British Journal of Cancer 1996;74:632-9.
34. Rosell R., Gomez-Codine J., Camps C.et al. A randomized trial comparing preoperative chemotherapy plus surgery with surgery alone in patients with non-small cell lung cancer. New England Journal of Medicine. 330:1994;153-158.
35. Roth JA, Fossella F, Komakir, et al. A randomized trial comparing peri-operative chemotherapy and surgery with surgery alone in resectable stage IIIa non-small cell lung cancer. Journal of National Cancer Institute 1994;86:650-1.
36. Saunders M., Dische S., Barret A.et al. CHART versus conventional radiotherapy in non-small-cell lung cancer. A randomized multicentre trial Lancet. 350:1997;161-165.
37. Green R.A., Humphrey E., Close H.et al. Alkylating agents in bronchogenic carcinoma. American Journal of Medicine. 46:1969;516.
38. Bunn PA Jr, Ihde DC. Small cell bronchogenic carcinoma: A review of therapeutic results. In: Livingston RB, editor. Lung Cancer1. The Hague, Martinus Nijhoff, 1981. p. 169.
39. Shepherd F.A. Small cell lung cancer. Chest Surgery and Clinics of North America. 7(1):1997;113-133.
40. Rusch V.W., Giroux D.J., Kraut M.J.et al. Induction chemoradiation and surgical resection for non-small cell lung carcinoma of the superior sulcus. initial results of Southwest Oncology Group Trial 9416 (Intergroup Trial 0160) Journal of Cardiovascular and Thoracic Surgery. 121(3):2001;472-483.
41. Richardson G.E., Thursfield V.J., Giles G.G. Reported management of lung cancer in Victoria in 1993. comparison with best practice. AntiCancer Council of Victoria Lung Cancer Study Group Medical Journal of Australia. 172(7):2000;321-324.
42. Kesson E, Buckall CE, McAlpine LG. Lung cancer - Management and outcome in Glasgow, 1991-92; 1998, British Journal Cancer 78(10).
43. Kotalik J., Yu E., Markman B.R.et al. Practice guideline on prophylactic cranial irradiation in small - cell lung cancer. International Journal of Radiation Oncology Biology Physics. 50(2):2001;309-316.
44. Evans W.K., Kocha W., Gagliardi A.et al. The use of gemcitabine in non-small-cell lung cancer. Provincial Lung Cancer Disease Site Group. Provincial Systemic Treatment Disease Site Group. Canadian Preventive Control. 3(1):1999;84-94.
45. Goss G., Paszat L., Newman T.E.et al. Use of preoperative chemotherapy with or without postoperative radiotherapy in technically resectable stage IIIA non-small-cell lung cancer. Provincial Lung Cancer Disease Site Group. Canadian Preventive Control. 2(1):1998;32-39.
46. Logan D.M., Lochrin C.A., Darling G.et al. Adjuvant radiotherapy and chemotherapy for stage II and IIIA non-small-cell lung cancer after complete resection. Provincial Lung Cancer Disease Site Group. Canadian Preventive Control. 1(5):1997;366-378.
47. Yu E., Lochrin C., Dixon P.et al. Altered fractionation of radical radiation therapy in the management of unresectable non-small cell lung cancer. Provincial Lung Disease Site Group. Current Oncology. 7(2):2000;98-109.
48. Walsh G.L., Winn R.J. Baseline institutional compliance with NCCN guidelines. nonsmall cell lung cancer Oncology. 11(11A):1997;161-170.
49. Rowell NP, Williams CJ. Radical radiotherapy for stage I/II non-small cell lung cancer in patients not sufficiently fit for or declining surgery (medically inoperable). Cochrane Database of Systematic Reviews. Issue 1, 2002.
50. Woolf S.H., Grol R., Hutchinson A.et al. Potential benefits, limitations and harms of clinical guidelines. British Medical Journal. 318:1999;527-530.
51. Browman GP. Improving clinical practice guidelines for the 21st century. Attitudinal barriers and not technology are the main challenges. International Journal of Techniques and Assessment in Health Care 16(4):959-68, Autumn 2000.
52. Alderson P., Roberts I. Should journals publish systematic reviews that find no evidence to guide practice? Examples from injury research. British Medical Journal. 320(7231):2002;376.